- Report
- October 2024
- 197 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- August 2023
- 146 Pages
Global
From €1348EUR$1,418USD£1,132GBP
€1797EUR$1,890USD£1,509GBP
- Report
- July 2020
- 118 Pages
Global
From €1205EUR$1,268USD£1,012GBP
€1607EUR$1,690USD£1,350GBP
- Report
- July 2018
- 108 Pages
Global
From €1416EUR$1,490USD£1,190GBP
- Report
- February 2024
- 120 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- December 2023
- 189 Pages
Global
€4749EUR$4,995USD£3,989GBP
The Cardiac Marker Analyzer market is a segment of the Pharmaceuticals industry that focuses on the development and production of medical devices used to detect and measure cardiac markers in the blood. These devices are used to diagnose and monitor cardiac diseases, such as heart failure, coronary artery disease, and myocardial infarction. Cardiac markers are proteins, enzymes, and other substances that are released into the bloodstream when the heart is damaged or stressed. The Cardiac Marker Analyzer market is driven by the increasing prevalence of cardiovascular diseases, technological advancements, and the growing demand for point-of-care testing.
Some of the major companies in the Cardiac Marker Analyzer market include Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Ortho Clinical Diagnostics, and Beckman Coulter. Show Less Read more